UroGen Pharma Ltd. Quarterly Unrecognized Tax Benefits in USD from Q4 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
UroGen Pharma Ltd. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2016 to Q2 2024.
  • UroGen Pharma Ltd. Unrecognized Tax Benefits for the quarter ending June 30, 2024 was $3.2M, a 6.67% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $3.2M +$200K +6.67% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $3.2M +$200K +6.67% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 $3.19M +$176K +5.83% Dec 31, 2023 10-K 2024-03-14
Q3 2023 $3M +$200K +7.14% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $3M +$200K +7.14% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $3M +$200K +7.14% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.02M +$176K +6.19% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $2.8M +$100K +3.7% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $2.8M +$100K +3.7% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $2.8M +$100K +3.7% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $2.84M +$125K +4.6% Dec 31, 2021 10-K 2024-03-14
Q3 2021 $2.7M +$2.7M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $2.7M Jun 30, 2021 10-Q 2021-08-04
Q1 2021 $2.7M Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $2.72M +$2.72M Dec 31, 2020 10-K 2023-03-24
Q3 2020 $0 Sep 30, 2020 10-Q 2020-11-09
Q4 2019 $0 Dec 31, 2019 10-K 2022-03-21
Q4 2017 $0 $0 Dec 31, 2017 20-F 2018-03-15
Q4 2016 $0 Dec 31, 2016 20-F 2018-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.